Skip to main content
logo
Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
25.79
-0.05 (-0.19%)
At close: Jul 2, 2026, 4:00 PM EDT
25.81
+0.02 (0.08%)
After-hours: Jul 2, 2026, 4:10 PM EDT

Arcutis Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-2.38-16.14-140.04-262.14-311.46-206.36
Depreciation & Amortization
2.254.671.960.750.930.45
Stock-Based Compensation
41.2840.3641.7338.8132.6823.89
Other Adjustments
1.290.31-0.73-0.9830.33.76
Change in Receivables
-58.96-73.16-47.26-17.35-8.46-
Changes in Inventories
-19.96-7.33-0.4-5.62-7.51-
Changes in Accounts Payable
3.61-1.692.233.151.570.25
Changes in Accrued Expenses
71.0350.0432.035.591.1910.46
Changes in Other Operating Activities
-11.07-2.69-1.68-9.283.04-7.09
Operating Cash Flow
26.99-5.63-112.16-247.06-257.72-174.63
Capital Expenditures
-0.08-0.69-0.14-0.43-0.33-1
Purchases of Intangible Assets
-5-10-5--22.95-
Purchases of Investments
-253.03-246.99-254.82-225.84-415.39-292.51
Proceeds from Sale of Investments
209.77227.42288.78406.5351.47217.55
Investing Cash Flow
-53.34-30.2528.82180.23-87.2-75.95
Long-Term Debt Issued
----12573.99
Long-Term Debt Repaid
---100---
Net Long-Term Debt Issued (Repaid)
---100-12573.99
Issuance of Common Stock
6.996.97166.2101.32178.99209.6
Net Common Stock Issued (Repurchased)
6.996.97166.2101.32178.99209.6
Other Financing Activities
-----2.19-1.64
Financing Cash Flow
7.656.9766.2101.32301.8281.95
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.050.17-0.24-0.05--
Net Cash Flow
-18.65-28.74-17.3734.45-43.1231.37
Free Cash Flow
26.92-6.31-112.3-247.49-258.05-175.62
FCF Margin
6.48%-1.68%-57.14%-415.20%-7000.76%-
Free Cash Flow Per Share
0.21-0.05-0.93-3.57-4.69-3.55
Levered Free Cash Flow
43.4126.17-206.04-267.97-187.57-129.29
Unlevered Free Cash Flow
51.2729.13-95-249.83-302.74-203.45
SEC Filings: 10-K · 10-Q